Legend Biotech Corporation Sponsored ADR (LEGN)

Last Closing Price: 28.95 (2025-05-30)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Legend Biotech Corporation Sponsored ADR (LEGN) had Net Income of $-177.03M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$627.24M
Net Income
$-177.03M
$234.58M
$392.66M
$759.34M
$-132.09M
$-26.04M
$-158.13M
$-153.71M
$-177.03M
$-177.03M
$-177.03M
$-173.13M
$-132.09M
$-108.74M
182.85M
182.85M
$-0.96
$-0.96
Balance Sheet Financials
$1.28B
$99.29M
$386.24M
$1.67B
$277.64M
$301.20M
$351.96M
$629.61M
$1.04B
$1.04B
$1.04B
183.65M
Cash Flow Statement Financials
$-144.03M
$-850.54M
$5.70M
$1.28B
$286.75M
$-990.96M
--
--
--
Fundamental Metrics & Ratios
4.62
--
--
0.22
0.33
62.60%
-21.06%
-21.06%
-17.34%
-25.21%
-28.22%
$-158.14M
--
--
--
0.38
9.81
99.77
3.66
-17.01%
-17.05%
-10.60%
-13.19%
$5.67
$-0.86
$-0.79